ID
20677
Description
Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00390520
Link
https://clinicaltrials.gov/show/NCT00390520
Keywords
Versions (2)
- 3/10/17 3/10/17 -
- 3/10/17 3/10/17 -
Uploaded on
March 10, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes Mellitus, Type 2 NCT00390520
Eligibility Diabetes Mellitus, Type 2 NCT00390520
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Diabetes Mellitus, Insulin-Dependent
Data type
boolean
Alias
- UMLS CUI [1]
- C0011854
Description
Complication Diabetic Metabolic
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0342257
- UMLS CUI [1,2]
- C0311400
Description
Complications of Diabetes Mellitus Evidence
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0342257
- UMLS CUI [1,2]
- C0332120
Description
Insulin regime
Data type
boolean
Alias
- UMLS CUI [1]
- C0557978
Description
Clinical Trial Eligibility Criteria Study Protocol
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1516637
- UMLS CUI [1,2]
- C2348563
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00390520
- StudyEvent: Eligibility
C0449238 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0439165 (UMLS CUI [1,2])
C0311400 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])